Evidence map›Paper›PMID 33171192›Full record

ArticleExperimental eye research2021

Using retinal function to define ischemic exclusion criteria for animal models of glaucoma.

Bailey G Hannon, Andrew J Feola, Brandon G Gerberich, A Thomas Read, Mark R Prausnitz, C Ross Ethier, Machelle T Pardue

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Development of an Automated Electroretinography Analysis Approach.Translational vision science & technology · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bailey G HannonGeorge W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Andrew J FeolaWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; Center for Visual and Neurocognitive Rehabilitation, Atlanta Veteran Affairs Healthcare System, Atlanta, GA, USA.
Brandon G GerberichWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
A Thomas ReadCenter for Visual and Neurocognitive Rehabilitation, Atlanta Veteran Affairs Healthcare System, Atlanta, GA, USA.
Mark R PrausnitzWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
C Ross EthierGeorge W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
Machelle T PardueWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; Center for Visual and Neurocognitive Rehabilitation, Atlanta Veteran Affairs Healthcare System, Atlanta, GA, USA. Electronic address: machelle.pardue@bme.gatech.edu.
Georgia Institute of Technology · USAtlanta VA Health Care System · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI NICKERSON, JOHN M · 1986 to 2025
$15.3M
VIsion Science Training in AtlantaT32EY007092 · NEI · EMORY UNIVERSITY · PI Machelle T. Pardue · 1985 to 2026
$4.6M
Targeting Scleral Stiffness as a Novel Therapeutic Approach in GlaucomaR01EY025286 · NEI · GEORGIA INSTITUTE OF TECHNOLOGY · PI ETHIER, C ROSS · 2015 to 2019
$2.5M
The Effect of Estrogen Deficiencies on Vision Loss in GlaucomaIK2RX002342 · VA · VETERANS HEALTH ADMINISTRATION · PI FEOLA, ANDREW J · 2018 to 2023
–
RR&D Research Career Scientist Award ApplicationIK6RX003134 · VA · VETERANS HEALTH ADMINISTRATION · PI PARDUE, MACHELLE T. · 2019 to 2025
–
BLRD VA I01 BX002439NEI NIH HHS P30 EY006360NEI NIH HHS R01 EY025286NEI NIH HHS T32 EY007092RRD VA IK2 RX002342RRD VA IK6 RX003134
6 · The paper itself

Abstract

Most animal models of glaucoma rely on induction of ocular hypertension (OHT), yet such models can suffer from high IOPs leading to undesirable retinal ischemia. Thus, animals with IOPs exceeding a threshold (e.g. > 60 mmHg) are often excluded from studies. However, due to the intermittent nature of IOP measurements, this approach may fail to detect ischemia. Conversely, it may also inappropriately eliminate animals with IOP spikes that do not induce ischemic damage. It is known that acute ischemia selectively impairs inner retinal function, which results in a reduced b-wave amplitude. Here, we explore the potential of using electroretinography (ERG) to detect ischemic damage in OHT eyes. 74 Brown Norway rats received a unilateral injection of magnetic microbeads to induce OHT, while contralateral eyes served as controls. IOP was measured every 2-3 days for 14 days after microbead injection. Retinal function was evaluated using dark-adapted bright flash ERG (2.1 log cd•s/m

Indexed as

AnimalsDark AdaptationDisease Models, AnimalElectroretinographyGlaucomaIntraocular PressureIschemiaMaleRatsRats, Inbred BNRetinal Ganglion CellsElectroretinographyGlaucomaIntraocular pressureIschemiaMicrobead modelOcular hypertension

Identifiers

PMID33171192
PMCPMC7856020
OpenAlexW3101907584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.